Lian Zhang
Beijing, 100034, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Metabolic syndrome is associated with improved cancer-specific survival in patients with localized clear cell renal cell carcinoma.
Journal: Translational andrology and urology
Published: December 07, 2019
Epigenetic inactivation of the candidate tumor suppressor gene ASC/TMS1 in human renal cell carcinoma and its role as a potential therapeutic target.
Journal: Oncotarget
Published: April 12, 2015
Frequent epigenetic suppression of tumor suppressor gene glutathione peroxidase 3 by promoter hypermethylation and its clinical implication in clear cell renal cell carcinoma.
Journal: International journal of molecular sciences
Published: March 28, 2015
Hypermethylation of the 16q23.1 tumor suppressor gene ADAMTS18 in clear cell renal cell carcinoma.
Journal: International journal of molecular sciences
Published: September 14, 2014
DLEC1, a 3p tumor suppressor, represses NF-κB signaling and is methylated in prostate cancer.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: September 01, 2014
KCNJ1 inhibits tumor proliferation and metastasis and is a prognostic factor in clear cell renal cell carcinoma.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: July 28, 2014
Interferon regulatory factor 8 functions as a tumor suppressor in renal cell carcinoma and its promoter methylation is associated with patient poor prognosis.
Journal: Cancer letters
Published: May 06, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026